A detailed history of Frisch Financial Group, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Frisch Financial Group, Inc. holds 2,161 shares of LLY stock, worth $1.94 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
2,161
Previous 2,645 18.3%
Holding current value
$1.94 Million
Previous $1.54 Million 9.01%
% of portfolio
0.56%
Previous 0.58%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $286,624 - $383,463
-484 Reduced 18.3%
2,161 $1.68 Million
Q4 2023

Feb 12, 2024

BUY
$525.19 - $619.13 $46,216 - $54,483
88 Added 3.44%
2,645 $1.54 Million
Q2 2023

Aug 11, 2023

SELL
$350.74 - $468.98 $240,256 - $321,251
-685 Reduced 21.13%
2,557 $1.2 Million
Q1 2023

May 11, 2023

BUY
$310.63 - $364.82 $8,697 - $10,214
28 Added 0.87%
3,242 $1.11 Million
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $66,882 - $77,931
208 Added 6.92%
3,214 $1.18 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $10,080 - $11,487
34 Added 1.14%
3,006 $972,000
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $1,393 - $1,636
5 Added 0.17%
2,972 $964,000
Q1 2022

May 10, 2022

BUY
$234.69 - $291.66 $1,408 - $1,749
6 Added 0.2%
2,967 $850,000
Q4 2021

Feb 09, 2022

BUY
$224.85 - $279.04 $1,349 - $1,674
6 Added 0.2%
2,961 $818,000
Q3 2021

Nov 16, 2021

BUY
$221.6 - $272.71 $654,828 - $805,858
2,955 New
2,955 $683,000
Q3 2021

Nov 10, 2021

SELL
$221.6 - $272.71 $653,276 - $803,949
-2,948 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$180.55 - $233.54 $1,083 - $1,401
6 Added 0.2%
2,948 $677,000
Q1 2021

May 13, 2021

BUY
$164.32 - $212.72 $35,328 - $45,734
215 Added 7.88%
2,942 $550,000
Q4 2020

Jan 26, 2021

BUY
$130.46 - $172.63 $1,043 - $1,381
8 Added 0.29%
2,727 $460,000
Q3 2020

Nov 10, 2020

SELL
$146.22 - $169.13 $6,872 - $7,949
-47 Reduced 1.7%
2,719 $403,000
Q2 2020

Aug 06, 2020

BUY
$136.42 - $164.18 $1,091 - $1,313
8 Added 0.29%
2,766 $454,000
Q1 2020

May 08, 2020

SELL
$119.05 - $147.35 $46,548 - $57,613
-391 Reduced 12.42%
2,758 $383,000
Q4 2019

Jan 28, 2020

BUY
$106.92 - $132.43 $43,730 - $54,163
409 Added 14.93%
3,149 $414,000
Q3 2019

Nov 05, 2019

BUY
$106.79 - $116.16 $961 - $1,045
9 Added 0.33%
2,740 $306,000
Q2 2019

Aug 08, 2019

SELL
$110.79 - $129.32 $66,584 - $77,721
-601 Reduced 18.04%
2,731 $303,000
Q1 2019

May 06, 2019

BUY
$111.31 - $131.02 $23,931 - $28,169
215 Added 6.9%
3,332 $432,000
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $330,090 - $369,800
3,117 New
3,117 $361,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $853B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Frisch Financial Group, Inc. Portfolio

Follow Frisch Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frisch Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Frisch Financial Group, Inc. with notifications on news.